Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACOS: N-acetylcysteine for Bipolar Depression
NCT02294591Phase 2Completed
- Sponsor
- Region Syddanmark
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in bipolar disorder (BD), sponsored by Region Syddanmark. Started Nov 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02294591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294591.